1. Home
  2. TMC vs NVAX Comparison

TMC vs NVAX Comparison

Compare TMC & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TMC the metals company Inc.

TMC

TMC the metals company Inc.

N/A

Current Price

$2.28

Market Cap

2.1B

ML Signal

N/A

Logo Novavax Inc.

NVAX

Novavax Inc.

N/A

Current Price

$8.52

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TMC
NVAX
Founded
2011
1987
Country
Canada
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.1B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
TMC
NVAX
Price
$2.28
$8.52
Analyst Decision
Buy
Buy
Analyst Count
6
9
Target Price
$10.90
★ $14.11
AVG Volume (30 Days)
4.5M
★ 6.1M
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
232.00
★ 309.76
EPS
★ 0.25
N/A
Revenue
N/A
★ $1,123,479,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.28
★ N/A
Revenue Growth
N/A
★ 64.69
52 Week Low
$1.91
$6.20
52 Week High
$10.05
$13.39

Technical Indicators

Market Signals
Indicator
TMC
NVAX
Relative Strength Index (RSI) 38.23 37.52
Support Level $1.91 $7.81
Resistance Level $2.97 $10.53
Average True Range (ATR) 0.25 0.76
MACD 0.04 -0.16
Stochastic Oscillator 33.97 5.98

Price Performance

Historical Comparison
TMC
NVAX

About TMC TMC the metals company Inc.

TMC The Metals Co Inc is a deep seabed minerals developer focused on the collection, processing and refining of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone (CCZ), approximately 1,500 miles (or 2,400 kilometers) south-west of San Diego, California. The company operates as a single operating and reportable segment, namely exploration of seafloor polymetallic nodules, which includes the development of a metallurgical process to treat such seafloor polymetallic nodules.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: